Appili Therapeutics Inc experienced a significant drop of 33.33% in its stock price, closing at just CA$0.01.
In the latest trading session, Appili Therapeutics Inc (APLI.TO) faced a downturn, losing over a third of its value. This decline raises concerns about the company's financial health and future prospects, especially with a current market cap of just CA$1.99 million.
Investor takeaway: Investors should be cautious and closely monitor Appili's financial performance and strategic decisions, particularly in light of today's steep decline.
Advertisement
Get up to $2,000 cash back
Open and fund a new Qtrade account with promo code SPRING26. Offer ends July 31, 2026.
Appili Therapeutics Inc
APLI.TO
APLI.TO
Appili Therapeutics Inc
WealthAwesomeMarket cap
$1.99M
52W high
$0.04
52W low
$0.01
1W change
+0.00%
Beta
-0.21
Analyst Price Targets
Based on analyst covering APLI
Wall Street analysts forecast APLI stock price to rise 900.0% over the next 12 months.
Consensus
No RatingAvg. Target
C$0.15
+900.0% Upside
Current Price
C$0.01
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on APLI's historical volatility
30-Day Vol
169.6%
Annualized
90-Day Vol
206.5%
Annualized
Trend (90d)
+0.0%
Annualized drift
90d Mean
C$0.02
Expected price
| Horizon | Expected | 68% Range (1ฯ) |
|---|---|---|
| 30 trading days | C$0.02 | C$0.01 โ C$0.03 |
| 60 trading days | C$0.02 | C$0.01 โ C$0.03 |
| 90 trading days | C$0.02 | C$0.01 โ C$0.04 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ยฑ1ฯ, 95% band = ยฑ2ฯ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Bull case
If Appili can successfully address its pipeline challenges and make the most of its FDA-approved products, there might be a chance for recovery.
Bear case
Ongoing financial instability and a lack of positive news could further shake investor confidence, leading to even greater losses.
Understanding the Decline
Appili Therapeutics Inc's recent drop of 33.33% has raised significant concerns among investors. The company has faced challenges in its pipeline and financial performance, with its stock closing at a mere CA$0.01. This decline follows a period of uncertainty regarding its operational results and strategic direction.
Market Reaction and Future Outlook
The market's response to Appili's performance shows a lack of confidence in the company's ability to recover. With a market cap now at just CA$1.99 million, investors are left questioning the viability of their investments. Future announcements about financial health and operational advancements will be crucial in determining whether the stock can regain its footing. For more insights, check out our detailed analysis on Appili Therapeutics.
Advertisement
